BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
出版年份 2013 全文链接
标题
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
作者
关键词
-
出版物
Cancer Medicine
Volume -, Issue -, Pages n/a-n/a
出版商
Wiley
发表日期
2013-08-20
DOI
10.1002/cam4.112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization
- (2012) Haruyuki Hongo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
- (2012) Yan Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease
- (2011) Simone Fulda et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibition of HIF Prolyl Hydroxylase-2 Blocks Tumor Growth in Mice through the Antiproliferative Activity of TGF
- (2011) A. K.-v. Ameln et al. CANCER RESEARCH
- Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I Activity
- (2011) Daniel Tello et al. Cell Metabolism
- Targeting mitochondria as a therapeutic target in cancer
- (2011) Charles E. Wenner JOURNAL OF CELLULAR PHYSIOLOGY
- Myocardial transcriptome analysis of human arrhythmogenic right ventricular cardiomyopathy
- (2011) Anna Gaertner et al. PHYSIOLOGICAL GENOMICS
- Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies
- (2010) Fernanda Martins Lopes et al. BRAIN RESEARCH
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
- (2008) Martina Klein et al. CIRCULATION
- PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells
- (2008) Sanjeewani T. Palayoor et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1
- (2008) M. Y. Koh et al. MOLECULAR CANCER THERAPEUTICS
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of Angiogenesis Through Stabilization of Hypoxia-inducible Factor-1 by Silencing Prolyl Hydroxylase Domain-2 Gene
- (2008) Shourong Wu et al. MOLECULAR THERAPY
- Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells
- (2008) Andrey V Kuznetsov et al. Nature Protocols
- A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation
- (2008) X. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now